Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by TBrady12on Nov 18, 2016 2:25pm

147 Views

Post# 25482297

RE:RE:RE:Anyone buying

You guys are taking a huge gamble this is going to drop back down.. I can't see this stock hitting lower than .17 cents a share again. I've mentioned I've been in since .03 and up I don't plan on selling my shares anytime soon. Once the guys get sick of CGC,ACB,APH,OGI there going to look to cheaper companies in the MJ business and this stock is going to sky rocket. Take the risk if you want but I certainly won't be selling one share of mine until this sniffs the 2 dollar range! GLTA and DD!

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December